Status:
COMPLETED
Evaluation of Heparin Bonded Vascular Graft Versus Standard Graft in Prosthetic Arteriovenous Access for Hemodialysis
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Hemodialysis Fistula Thrombosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The majority of bridge graft fistula with polytetrafluoroethylene (PTFE) for hemodialysis access will develop stenosis at the venous anastomosis and eventually will fail. Aspirin have been used for ma...
Eligibility Criteria
Inclusion
- All the patients who are scheduled for the creation of a new prosthetic access with informed consent will be enrolled in the trial
- Investigators will attempt to enroll a male:female ratio of patients representative of their current patient population
Exclusion
- Anticoagulation therapy
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00737620
Start Date
March 1 2008
Last Update
October 30 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare Zedek Medical Center, Jerusalem
Jerusalem, Israel